BACKGROUND Treatment of multivessel coronary artery disease with traditional single-arterial coronary artery bypass
Note, in such patients, a second repeat PCI (third overall) was counted as a reintervention event.
STATISTICAL ANALYSIS. The 4 PCI and CABG treatment study cohorts exhibited substantial demographic and risk factor differences ( Table 1 ) that confound between-groups outcome comparisons. As a primary approach to obtain risk-adjusted PCI versus CABG outcome comparisons, we used propensity score matching-applied to 2 treatment groups at a time-to derive balanced demographic and risk factor subcohorts. Specifically, 4 matched patient-pair groups (1 PCI, 1 CABG) were based on propensity score models calculated separately for BMS-PCI and SA-CABG, BMS-PCI and MA-CABG, DES-PCI and SA-CABG, and DES-PCI and MA-CABG.
All propensity models considered PCI as treatment for the calculation of probability of PCI via nonparsimonious logistic multivariate models using 21 demographics and preoperative risk factors. Left main disease was not included in the propensity model given its relative rarity in PCI-treated patients versus CABG-treated (5% vs. 32%) so as not to severely limit the matching of patients. A 1-to-1 greedy propensity score matching was obtained in each case and always to the closest available score and within AE1% difference. Patient factors for matched patient groups were compared to ensure matching adequacy defined as standardized differences <10% for all continuous and categorical variables (30) .
Continuous data were expressed as mean AE SD.
When applicable, univariate comparisons were done with chi-square or Fisher exact tests for categorical *Definition of planned PCI provided under Outcomes and Follow-up in the Methods section. Abbreviations as in Figure 1 .
Optimal Revascularization of Multivessel CAD The p values were derived by log-rank test. Abbreviations as in Figure 1 .
Habib et al. 3,8,9 ). In addition, conventional SA-CABG is associated with better intervention-free survival than PCI-DES is, whereas the 2 methods showed similar late death-free survival following a brief trend (0 to 3 years) of SA-CABG superiority (Central Illustration).
S E P T E M B E R
Multiple randomized prospective studies were published in the past decade comparing surgical approaches versus percutaneous approaches (1-6). Their results mostly showed equivalent long-term survival with both modalities albeit at the expense of more frequent reintervention, yet these had limited applicability to the "real-world" scenarios confronting clinicians given the relatively healthy and highly selective nature of these trials' populations (7, 31) . 
